Treatment of Vulvovaginal Candidiasis
For uncomplicated vulvovaginal candidiasis, treat with either topical azole antifungals (intravaginal for 1-7 days) or a single 150 mg oral dose of fluconazole, both achieving 80-90% cure rates. 1
First-Line Treatment Options
Oral Therapy
- Fluconazole 150 mg as a single oral dose is highly effective for uncomplicated VVC, achieving therapeutic cure rates of 55% (complete symptom resolution plus negative culture) and clinical cure rates of 69% 2, 1
- Oral fluconazole offers convenience but causes more gastrointestinal side effects (16% vs 4% with vaginal products), including nausea (7%), abdominal pain (6%), and diarrhea (3%) 2
Topical Intravaginal Therapy
Over-the-counter options (no prescription required):
- Clotrimazole 1% cream 5g daily for 7-14 days 1
- Clotrimazole 2% cream 5g daily for 3 days 1
- Miconazole 2% cream 5g daily for 7 days 1
- Miconazole 4% cream 5g daily for 3 days 1
- Miconazole 100 mg suppository daily for 7 days 1
- Miconazole 200 mg suppository daily for 3 days 1
- Miconazole 1200 mg suppository as single dose 1
- Tioconazole 6.5% ointment 5g as single application 1
Prescription intravaginal options:
- Butoconazole 2% cream 5g as single application (bioadhesive formulation) 1
- Terconazole 0.4% cream 5g daily for 7 days 1
- Terconazole 0.8% cream 5g daily for 3 days 1
- Terconazole 80 mg suppository daily for 3 days 1
Treatment Selection Algorithm
For Uncomplicated VVC (mild-to-moderate, sporadic, first episode)
- Single-dose or short-course (1-3 day) regimens are appropriate 1
- Choose based on patient preference: oral fluconazole for convenience vs topical therapy to avoid systemic side effects 2
- Topical azoles achieve 80-90% symptom relief and negative cultures 1
For Complicated VVC (severe symptoms, recurrent disease, diabetes, immunocompromised)
- Use longer duration therapy: 7-14 day topical azole regimens 1
- Avoid single-dose treatments in these populations 1
For Pregnancy
- Use ONLY topical azole therapy; oral fluconazole is contraindicated 3, 1
- Recommend 7-day regimens as they are more effective than shorter courses during pregnancy 3
- Preferred options: Clotrimazole 1% cream for 7-14 days or Miconazole 2% cream for 7 days 3
For HIV-Infected Women
- Treat with the same regimens as HIV-negative women 1
- VVC may be more severe but responds to standard therapy 1
Important Clinical Considerations
Diagnosis Confirmation
- Do not treat based on symptoms alone—less than 50% of women self-diagnosing VVC actually have it 1
- Confirm diagnosis with wet mount showing yeast/pseudohyphae OR positive culture 1
- Vaginal pH remains ≤4.5 with Candida infection (unlike bacterial vaginosis or trichomoniasis) 1, 3
- 10% KOH preparation improves visualization of yeast forms 1
Common Pitfalls to Avoid
- Do not treat asymptomatic colonization—10-20% of women harbor Candida without symptoms 1
- Do not routinely treat sexual partners as VVC is not sexually transmitted 1
- Only treat male partners if they have symptomatic balanitis (erythema and pruritus on glans) 1
- Patients should return only if symptoms persist or recur within 2 months 1
Self-Treatment Guidelines
- OTC self-treatment is appropriate ONLY for women with previously diagnosed VVC experiencing identical recurrent symptoms 1
- Any woman with persistent symptoms after OTC treatment or recurrence within 2 months must seek medical evaluation 1
Drug Resistance and Non-Albicans Species
- C. albicans causes 74% of cases and is usually azole-sensitive 4
- C. glabrata (20% of cases) may require longer treatment courses 4
- Consider culture and sensitivity testing for recurrent cases or treatment failures 5
Adverse Effects
- Topical agents: local burning or irritation (generally well-tolerated) 1
- Oral fluconazole: headache (13%), nausea (7%), abdominal pain (6%), rare hepatotoxicity 2
- Serious hepatic reactions with oral azoles are rare but can be fatal, particularly in patients with AIDS or malignancy taking multiple medications 2